Publicaciones (31) Publicaciones de Paula Leticia Tejera Álvarez

2023

  1. Editorial: Current omics-based approaches as tools for improving the understanding, diagnosis and management of inflammatory lung disease

    Frontiers in Medicine

2021

  1. Editorial: Precision Medicine in Pulmonary Diseases—Same Principles, New Approach

    Frontiers in Medicine

  2. Integrative omics provide biological and clinical insights into acute respiratory distress syndrome

    Intensive Care Medicine, Vol. 47, Núm. 7, pp. 761-771

  3. Plasma Insulin-like Growth Factor Binding Protein 7 Contributes Causally to ARDS 28-Day Mortality: Evidence From Multistage Mendelian Randomization

    Chest, Vol. 159, Núm. 3, pp. 1007-1018

2020

  1. Plasma Levels of Proresolving and Prophlogistic Lipid Mediators: Association With Severity of Respiratory Failure and Mortality in Acute Respiratory Distress Syndrome

    Critical Care Explorations, Vol. 2, Núm. 10, pp. E0241

2019

  1. Deconstructing ARDS Variability: Platelet Count, an ARDS Intermediate Phenotype and Novel Mediator of Genetic Effects in ARDS

    Seminars in Respiratory and Critical Care Medicine, Vol. 40, Núm. 1, pp. 12-18

2017

  1. A missense genetic variant in LRRC16A/CARMIL1 improves acute respiratory distress syndrome survival by attenuating platelet count decline

    American Journal of Respiratory and Critical Care Medicine, Vol. 195, Núm. 10, pp. 1353-1361

  2. Late-onset moderate to severe acute respiratory distress syndrome is associated with shorter survival and higher mortality: a two-stage association study

    Intensive Care Medicine, Vol. 43, Núm. 3, pp. 399-407

  3. Whole blood microRNA markers are associated with acute respiratory distress syndrome

    Intensive Care Medicine Experimental , Vol. 5, Núm. 1

2015

  1. B cell-activating factor an orchestrator of lymphoid follicles in severe chronic obstructive pulmonary disease

    American Journal of Respiratory and Critical Care Medicine, Vol. 192, Núm. 6, pp. 695-705

  2. Platelet count mediates the contribution of a genetic variant in LRRC16A to ARDS risk

    Chest, Vol. 147, Núm. 3, pp. 607-617

  3. Predictors of circulating insulin-like growth factor-1 and insulin-like growth factor-binding protein-3 in critical illness

    Critical Care Medicine, Vol. 43, Núm. 12, pp. 2651-2659

2014

  1. Functional characterization of polymorphisms in the peptidase inhibitor 3 (Elafin) gene and validation of their contribution to risk of acute respiratory distress syndrome

    American Journal of Respiratory Cell and Molecular Biology, Vol. 51, Núm. 2, pp. 262-272

2013

  1. IL 1RN coding variant is associated with lower risk of acute respiratory distress syndrome and increased plasma IL-1 receptor antagonist

    American Journal of Respiratory and Critical Care Medicine, Vol. 187, Núm. 9, pp. 950-959

2012

  1. Distinct and replicable genetic risk factors for acute respiratory distress syndrome of pulmonary or extrapulmonary origin

    Journal of Medical Genetics, Vol. 49, Núm. 11, pp. 671-680

  2. Inflammation and Immune-Related Candidate Gene Associations with Acute Lung Injury Susceptibility and Severity: A Validation Study

    PLoS ONE, Vol. 7, Núm. 12

2011

  1. Interleukin-1 receptor-associated kinase 3 gene associates with susceptibility to acute lung injury

    American Journal of Respiratory Cell and Molecular Biology, Vol. 45, Núm. 4, pp. 740-745

2010

  1. Ure2 is involved in nitrogen catabolite repression and salt tolerance via Ca2+ homeostasis and calcineurin activation in the yeast Hansenula polymorpha

    Journal of Biological Chemistry, Vol. 285, Núm. 48, pp. 37551-37560

2009

  1. Genetic polymorphisms of peptidase inhibitor 3 (elafin) are associated with acute respiratory distress syndrome

    American Journal of Respiratory Cell and Molecular Biology, Vol. 41, Núm. 6, pp. 696-704

  2. Genetic variants in the angiopoietin-2 gene are associated with increased risk of ARDS

    Intensive Care Medicine, Vol. 35, Núm. 6, pp. 1024-1030